FOXO4-DRI Handling Guide: Common Mistakes to Avoid
Most handling advice for research peptides is written generically. The practices below are the ones that specifically matter for FOXO4-DRI — including the mistakes it is unusually easy to make with this compound.
Overview
Let the vial warm to room temperature before opening, swirl rather than shake, use plastic low-bind tubes, and keep the liquid out of the light.
What FOXO4-DRI actually is
FOXO4-DRI is a lab-made peptide that blocks two proteins, FOXO4 and p53, from holding onto each other inside worn-out "senescent" cells. In the 2017 study that introduced it, breaking that grip caused senescent cells in the dish to self-destruct while healthy cells were left alone. It is studied in cell and animal research on how senescent cells build up with age and damage. You will also see it spelled FOX04-DRI (with a zero) or sold as Proxofim — same molecule.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Bench practices for FOXO4-DRI
- Let the vial reach room temperature before opening.
- Add diluent gently down the vial wall and swirl; do not vortex.
- Use low-bind polypropylene rather than glass for dilutions — the cationic tail adsorbs to glass.
- Protect solutions from light.
The chemistry behind these practices
- Deamidation at the Asn-Gly motif in the sequence — the fastest-deamidating dipeptide in peptide chemistry.
- Oxidation of the single tryptophan residue on light and oxygen exposure.
- Adsorptive loss of the cationic peptide to glass and untreated plastic at low concentrations.
Storage summary
What FOXO4-DRI is studied for
The founding study showed that senescent cells rely on FOXO4 holding p53 in the nucleus. Interfering with that interaction caused p53 nuclear exclusion and intrinsic apoptosis selectively in senescent cells in culture (Baar et al., Cell 2017).
The same study examined doxorubicin-induced senescence, fast-ageing XpdTTD/TTD mice and naturally aged mice, reporting changes in fur density, fitness and renal markers.
Studied in hydrogen-peroxide-induced senescent TM3 Leydig cells and aged mice for effects on the testicular microenvironment (Zhang et al., Aging 2020).
At 25 µM in vitro it removed a large share of late-passage (senescent-enriched) human chondrocytes while sparing early-passage cells, without improving cartilage-forming capacity (Huang et al., Front Bioeng Biotechnol 2021).
Summarizes published preclinical literature — see the selected references below. Provided for research reference only; not a claim of efficacy or a description of human use.
- Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017.
- Zhang C, Xie Y, Chen H, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging (Albany NY). 2020.
- Huang Y, He Y, Makarcyzk MJ, Lin H Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes. Frontiers in Bioengineering and Biotechnology. 2021.
- Browse current FOXO4-DRI literature on PubMed
References describe in-vitro and preclinical research and are listed for reference only — not evidence of efficacy and not a description of human use.
More FOXO4-DRI reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Lab Handling reference for other compounds
Reviewed for research-use compliance by Kobi Williams, Founder — Popular Peptides Canada. Last reviewed 22 July 2026.
FOXO4-DRI is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.